PhysiologybioRxivPreprint
KRAS signalling in malignant pleural mesothelioma
A. Marazioti, A. Krontira, M. A. Pepe…·G. T. Stathopoulos
This study identifies KRAS mutations as a significant driver in human malignant pleural mesothelioma and demonstrates their role in disease initiation and treatment response in mouse models.